Last reviewed · How we verify

NCT04475406

Comparison of Short and Standard Dental Implants

Completed NA Last updated 20 July 2020
What this trial tests

NA trial testing PICF (Periopaper) in Peri-Implantitis in 60 participants. Completed in 20 December 2017.

Timeline
15 December 2016
Primary endpoint
20 March 2017
20 December 2017

Quick facts

Lead sponsorAlanya Alaaddin Keykubat University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingnone
Primary purposeprevention
Enrollment60
Start date15 December 2016
Primary completion20 March 2017
Estimated completion20 December 2017

Drugs / interventions tested

Conditions studied

Sponsor

Alanya Alaaddin Keykubat University

Who can join

Adults 35 to 66, any sex, with Peri-Implantitis or Peri-implant Mucositis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Objective: This study aimed to evaluate the total amounts of tumor necrosis factor α (TNF-α), prostaglandin E2 (PGE2), receptor activator of nuclear factor kappa B ligand (RANKL), receptor activator of nuclear factor kappa B (RANK), and osteoprotegerin (OPG) and the abundance of putative oral pathogens Fusobacterium nucleatum, Porphyromonas gingivalis, Treponema denticola, Tannerella forsythia, Prevotella intermedia, and Streptococcus oralis in extra short and standard dental implants functioning in the posterior mandible. Methodology: The implants were divided into two groups according to their lengths: standard (intrabony length ≥8 mm) and extra short (intrabony length ≤ 6 mm). A total of 60 implants were researched in 30 patients. Probing depth (PD), clinical attachment level (CAL), presence of bleeding on probing (BOP), 3-year survival rate (CSR), and bone loss (BL) were measured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Comparison of Osteoimmunological and Microbiological Parameters of Extra Short and Longer Implants Loaded in the Posterior Mandible: A Split Mouth Randomized Clinical Study.
    Karcı BL, Oncu E. · · 2021 · cited 4× · PMID 34658370 · DOI 10.15644/asc55/3/1

Verify or expand the search:

Other recruiting trials for Peri-Implantitis

Currently open trials in the same condition.

Other Alanya Alaaddin Keykubat University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04475406.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing